Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ASTRAZENECA PHARMACEUTICALS LP
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-10-28 to 2021-06-30
Current total value of award: $0
Description: THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE ALL FUNDING AND TO ENTER INTO A BI-LATERAL NO-COST CANCELLATION OF THE CONTRACT